These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32245350)

  • 21. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
    Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlations between serum intact parathyroid hormone (PTH) and N-terminal-probrain natriuretic peptide levels in elderly patients with chronic heart failure (CHF).
    Zhang S; Hu Y; Zhou L; Chen X; Wang Y; Wu J; He H; Gao Y
    Arch Gerontol Geriatr; 2015; 60(2):359-65. PubMed ID: 25466512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NT-proBNP, IGF-I and survival in patients with chronic heart failure.
    Petretta M; Colao A; Sardu C; Scopacasa F; Marzullo P; Pivonello R; Fontanella L; de Caterina M; de Simone A; Bonaduce D
    Growth Horm IGF Res; 2007 Aug; 17(4):288-96. PubMed ID: 17383209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure.
    Lok DJ; Lok SI; Bruggink-André de la Porte PW; Badings E; Lipsic E; van Wijngaarden J; de Boer RA; van Veldhuisen DJ; van der Meer P
    Clin Res Cardiol; 2013 Feb; 102(2):103-10. PubMed ID: 22886030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between NT-proBNP levels, functional capacity and stage in patients with heart failure.
    Karabulut A; Kaplan A; Aslan C; Iltumur K; Toprak G; Toprak N
    Acta Cardiol; 2005 Dec; 60(6):631-8. PubMed ID: 16385925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of red cell distribution width and other red cell parameters in patients with chronic heart failure during two years of follow-up.
    Wołowiec Ł; Rogowicz D; Banach J; Buszko K; Surowiec A; Błażejewski J; Bujak R; Sinkiewicz W
    Kardiol Pol; 2016; 74(7):657-64. PubMed ID: 26779853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single sST2 protein measurement predicts adverse outcomes at 1-year follow-up in patients with chronic heart failure.
    Sobczak S; Wojtczak-Soska K; Ciurus T; Sakowicz A; Pietrucha T; Lelonek M
    Pol Arch Med Wewn; 2014; 124(9):452-8. PubMed ID: 25041760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure.
    Zhang J; Pellicori P; Pan D; Dierckx R; Clark AL; Cleland JGF
    Int J Cardiol; 2018 Oct; 269():196-200. PubMed ID: 30001941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial
    Verschure DO; Lutter R; van Eck-Smit BLF; Somsen GA; Verberne HJ
    J Nucl Cardiol; 2018 Jun; 25(3):845-853. PubMed ID: 27858345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure.
    Ahmad T; Fiuzat M; Neely B; Neely ML; Pencina MJ; Kraus WE; Zannad F; Whellan DJ; Donahue MP; Piña IL; Adams KF; Kitzman DW; O'Connor CM; Felker GM
    JACC Heart Fail; 2014 Jun; 2(3):260-8. PubMed ID: 24952693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal brain natriuretic peptide, but not anemia, is a powerful predictor of mortality in advanced heart failure.
    Gardner RS; Chong KS; Morton JJ; McDonagh TA
    J Card Fail; 2005 Jun; 11(5 Suppl):S47-53. PubMed ID: 15948101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.
    Tsutamoto T; Sakai H; Nishiyama K; Tanaka T; Fujii M; Yamamoto T; Horie M
    Circ J; 2007 Dec; 71(12):1873-8. PubMed ID: 18037739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional Handling and Prognostic Performance of Circulating Insulin-Like Growth Factor Binding Protein-7 in Heart Failure.
    Tan ESJ; Chan SP; Choi YC; Pemberton CJ; Troughton R; Poppe K; Lund M; Devlin G; Doughty RN; Richards AM
    JACC Heart Fail; 2023 Jun; 11(6):662-674. PubMed ID: 37286261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of timely measurement of galectin-3, NT-proBNP, cystatin C and hsTnT in predicting prognosis and heart function after heart transplantation.
    Franeková J; Hošková L; Sečník P; Pazderník M; Kotrbatá M; Kubíček Z; Jabor A
    Clin Chem Lab Med; 2016 Feb; 54(2):339-44. PubMed ID: 26351922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free triiodothyronine levels and short-term prognosis in chronic heart failure patients with type 2 diabetes.
    Chen P; Li S; Lei X; Liu Z; Wu D; Luo Y; Xu D
    Am J Med Sci; 2015 Aug; 350(2):87-94. PubMed ID: 26164865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure.
    Taniguchi R; Sato Y; Yamada T; Ooba M; Higuchi H; Matsumori A; Kimura T; Kita T
    Circ J; 2004 Dec; 68(12):1160-4. PubMed ID: 15564700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
    Leto L; Testa M; Feola M
    Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.